The use of PBSCs was associated with earlier engraftment but no significant survival benefit compared to bone marrow transplants during the same time period.
Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983--93 and ...
Dec 23, 2021 · Allogeneic hematopoietic stem cell transplantation (allo-SCT) can enable long-term survival or even cure in carefully selected patients with multiple myeloma ( ...
Allogeneic hematopoietic cell transplantation in multiple myeloma has evolved over the decades. Myeloablative regimens have been replaced by the reduced ...
People also ask
How successful is a stem cell transplant for multiple myeloma?
How many times can you have a stem cell transplant for multiple myeloma?
What is the benefit of PBSC compared to bone marrow stem cells?
What is allogeneic stem cell transplantation in multiple myeloma?
Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983-93 ...
Feb 1, 2019 · Our data suggest that allo-SCT may enable long-term survival and a potential cure in a carefully selected subgroup of MM patients with tolerable toxicity.
Missing: allogenic | Show results with:allogenic
A stem cell or bone marrow transplant may be a treatment option for patients with certain blood cancers or solid tumors. Learn more about this procedure.
Comparison of Outcomes of Allogeneic Hematopoietic Cell ...
www.astctjournal.org › article › fulltext
Highlights. •. There was no impact in myeloma survival outcomes by conditioning regimen intensity for allogeneic stem cell transplantation.
It is most often performed for patients with certain cancers of the blood or bone marrow, such as multiple myeloma, leukemia, some types of lymphoma and immune ...
The purpose of this study was to compare outcome of patients transplanted with either PBSC or bone marrow (BM) following RIC or myeloablative conditioning (MAC) ...